tiprankstipranks
Trending News
More News >
Prescient Therapeutics Limited (AU:PTX)
ASX:PTX
Australian Market
Advertisement

Prescient Therapeutics Limited (PTX) Income Statement

Compare
14 Followers

Prescient Therapeutics Limited Income Statement

Last quarter (Q4 2025), Prescient Therapeutics Limited's total revenue was AU$3.11M, an increase of 164.73% from the same quarter last year. In Q4, Prescient Therapeutics Limited's net income was AU$-4.87M. See Prescient Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 4.36MAU$ 3.71MAU$ 2.43MAU$ 1.89MAU$ 1.19M
Gross Profit
AU$ 4.36MAU$ 3.71MAU$ 2.43MAU$ 1.89MAU$ 1.19M
Operating Expenses
AU$ 11.89MAU$ 10.90MAU$ 9.88MAU$ 7.10MAU$ 5.43M
Depreciation and Amortization
AU$ 717.00AU$ 717.00AU$ 2.09KAU$ 1.40KAU$ 474.00
EBITDA
AU$ -7.54MAU$ -7.19MAU$ -7.46MAU$ -6.86MAU$ -5.32M
Operating Income
AU$ -7.54MAU$ -7.19MAU$ -9.89MAU$ -7.10MAU$ -5.43M
Other Income/Expenses
AU$ 213.23KAU$ -4.76MAU$ 513.36KAU$ 231.08KAU$ 92.81K
Pretax Income
AU$ -7.32MAU$ -11.95MAU$ -9.37MAU$ -6.87MAU$ -4.15M
Net Income
AU$ -7.32MAU$ -8.24MAU$ -7.00MAU$ -5.12MAU$ -4.15M
Per Share Metrics
Basic EPS
AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.01
Diluted EPS
AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.01
Weighted Average Shares Outstanding
804.76M 805.36M 727.53M 647.80M 611.80M
Weighted Average Shares Outstanding (Diluted)
805.31M 805.31M 727.53M 647.80M 611.80M
Currency in AUD

Prescient Therapeutics Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis